- ACTIVE INGREDIENT
- INACTIVE INGREDIENT
- PURPOSE
-
WARNINGS
1. If the following symptoms occur after product use, stop using the product immediately and consult a dermatologist (continuous use can exacerbate the symptoms).
1) Occurrence of red spots, swelling, itchiness, and other irritation
2) If the symptoms above occur after the application area is exposed to direct sunlight2. Do not use on open wounds, eczema, and other irritations
3. Precaution for Storage and Handling
1) Close the lid after use
2) Keep out of reach of infants and children
3) Do not to store in a place with high/low temperature and exposed to direct sunlight4. Use as avoiding eye areas.
- KEEP OUT OF REACH OF CHILDREN
- INDICATIONS & USAGE
- DOSAGE & ADMINISTRATION
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
MYRRH WOMAN
menthol pillProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:72263-0002 Route of Administration VAGINAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength MENTHOL (UNII: L7T10EIP3A) (MENTHOL - UNII:L7T10EIP3A) MENTHOL 0.5 g in 100 g Inactive Ingredients Ingredient Name Strength ADENOSINE (UNII: K72T3FS567) NIACINAMIDE (UNII: 25X51I8RD4) Product Characteristics Color gray Score no score Shape ROUND Size 10mm Flavor MENTHOL Imprint Code none Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72263-0002-1 4 g in 1 BOTTLE; Type 0: Not a Combination Product 04/27/2018 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 04/27/2018 Labeler - MIR BIOTECHNOLOGY (694203851) Registrant - MIR BIOTECHNOLOGY (694203851) Establishment Name Address ID/FEI Business Operations MIR BIOTECHNOLOGY 694203851 manufacture(72263-0002)